The Valley Desk

NCT02447887 · Interventional trial

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Metastatic Renal Cell Carcinoma, RCC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov